期刊
CHEMICAL SCIENCE
卷 3, 期 6, 页码 1829-1834出版社
ROYAL SOC CHEMISTRY
DOI: 10.1039/c2sc20273e
关键词
-
资金
- Packard Foundation
- Amgen
- Astra Zeneca
- Novartis
- National Institute of General Medical Sciences [NIH GM 79465]
- Royal Commission for the Exhibition
- UC Berkeley
We present the synthesis and characterization of octaarginine-conjugated Copper-Gad-2 (Arg(8)CG2), a new copper-responsive magnetic resonance imaging (MRI) contrast agent that combines a Gd3+-DO3A scaffold with a thioether-rich receptor for copper recognition. The inclusion of a polyarginine appendage leads to a marked increase in cellular uptake compared to previously reported MRI-based copper sensors of the CG family. Arg8CG2 exhibits a 220% increase in relaxivity (r(1) = 3.9 to 12.5 mM(-1) s(-1)) upon 1 : 1 binding with Cu+, with a highly selective response to Cu+ over other biologically relevant metal ions. Moreover, Arg(8)CG2 accumulates in cells at nine-fold greater concentrations than the parent CG2 lacking the polyarginine functionality and is retained well in the cell after washing. In cellulo relaxivity measurements and T-1-weighted phantom images using a Menkes disease model cell line demonstrate the utility of Arg(8)CG2 to report on biological perturbations of exchangeable copper pools.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据